ISRCTN04481866已完成不适用
A double-blind, placebo-controlled parallel-group pilot study of the effectiveness of D-cycloserine in reducing craving during cue-exposure therapy in abstinent alcohol-dependant subjects
Record Provided by the NHSTCT Register - 2006 Update - Department of Health0 个研究点目标入组 24 人开始时间: 2006年9月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •24 abstinent alcohol dependant males who attend the Bristol Area Specialist Alcohol Service. 12 in each group, D-cycloserine and placebo
排除标准
- •1. Substance misuse or dependence (other than alcohol)
- •2. Major psychiatric morbidity such as psychosis
- •3. Clinically significant abnormality on physical examination or investigation
- •4. Pregnancy or breast feeding
- •5. Taking acamprosate, disulfiram or naltrexone
研究者
相似试验
进行中（未招募）
不适用
A double-blind, placebo-controlled parallel-group study to assess the efficacy, safety, and tolerability of CAT-354MedDRA version: 9.1Level: PTClassification code 10003553Term: AsthmaAsthmaEUCTR2007-002090-31-NLMedImmune Limited80
进行中（未招募）
1 期
A double-blind, placebo-controlled parallel-group study to assess the efficacy, safety, and tolerability of CAT-354MedDRA version: 8.1 Level: PT Classification code 10003553 Term: AsthmaAsthmaEUCTR2007-002090-31-GBMedImmune Limited14
进行中（未招募）
不适用
A double-blind, placebo-controlled parallel-group study to assess the efficacy, safety, and tolerability of CAT-354MedDRA version: 9.1Level: PTClassification code 10003553Term: AsthmaAsthmaEUCTR2007-002090-31-DEMedImmune Limited80
进行中（未招募）
1 期
A double-blind, placebo-controlled, parallel-group, multi-center study to investigate the effect of Omacor? (n-3 PUFA) on lipid parameters in HIV infected patients treated with HAARTHAART-induced hypertriglyeridemia in HIV infected subjectsMedDRA version: 9.1 Level: LLT Classification code 10020869 Term: HypertriglyceridaemiaEUCTR2007-001921-86-GBSolvay Pharmaceuticals GmbH65
进行中（未招募）
不适用
A double-blind, placebo-controlled, parallel-group, multi-center study to investigate the effect of Omacor? (n-3 PUFA) on lipid parameters in HIV infected patients treated with HAARTHAART-induced hypertriglyeridemia in HIV infected subjectsMedDRA version: 9.1Level: LLTClassification code 10020869Term: HypertriglyceridaemiaEUCTR2007-001921-86-DESolvay Pharmaceuticals GmbH65